John Buergler is a Cardiology physician affiliated with Houston Methodist. OpenAlex indexes 42 publications with 649 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6550 Fannin St
Smith Tower, Suite 1901
Houston, TX 770302717
Telephone
713-441-1100Registry record last updated 1 Jun 2015.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Edwards Lifesciences CorporationProgram year20251 payment
- E.R. Squibb & Sons, L.L.C.Program year20252 payments
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
81.7%Statin19.7%Atorvastatin Calcium63%Rosuvastatin Calcium28%Pravastatin Sodium7%Simvastatin2%Part D<11 patientsBeta blocker13.9%Metoprolol Succinate53%Metoprolol Tartrate27%Carvedilol17%Labetalol Hcl4%Part D<11 patients+ 17 more classes in this area
Blood & clotting
15%Factor Xa inhibitor8.9%Eliquis78%Xarelto22%Part D≥71 patientsP2Y12 inhibitor5.2%Clopidogrel94%Brilinta6%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
3.3%Potassium supplement1.8%Potassium Chloride100%Part D≥23 patientsProton pump inhibitor1%Pantoprazole Sodium73%Esomeprazole Magnesium27%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- MULTIMODALITY IMAGING AS A TOOL TO DIAGNOSE EOSINOPHILIC CARDIOMYOPATHY
Journal of the American College of Cardiology
2025 - Early Observations on Effects of Mavacamten on Left Atrial Function in Obstructive Hypertrophic Cardiomyopathy Patients
JACC. Cardiovascular imaging
2023 - TCT-608 Impact of Frailty on Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Chronic Total Occlusion
Journal of the American College of Cardiology
2023 - Atypical Presentation of Takotsubo Cardiomyopathy in an Elderly Woman
Methodist DeBakey Cardiovascular Journal
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Neal Kleiman, MD
Houston Methodist
William Zoghbi, MD
Houston Methodist
Eleftherios Mylonakis, MD
Houston Methodist
Dipan Shah, MD
Houston Methodist
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”